Maya Gutierrez

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

Chad J. Creighton, Xiaoxian Li, Melissa D. Landis et al. · Proceedings of the National Academy of Sciences · 2009 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +16

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

Jenny C. Chang, Eric C. Wooten, Anna Tsimelzon et al. · The Lancet · 2003 · 885 citations

Life Sciences, Oncology, Pharmacology +16

Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study

Thomas Bachelot, Gilles Romieu, Mario Campone et al. · The Lancet Oncology · 2012 · 742 citations

Medicine, Oncology, Pharmacology +16

Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase

Maya Gutierrez, Simone Detre, Stephen Johnston et al. · Journal of Clinical Oncology · 2005 · 489 citations · Full text

Medicine, Cancer Biology, Oncology +15

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Bhuvanesh Dave, Ilenia Migliaccio, Maya Gutierrez et al. · Journal of Clinical Oncology · 2010 · 256 citations

Medicine, Oncology, Pharmacology +17